(1) Complement hemolytic activity (CH50) was lower in the CSF from sCJD patients. CH50 was consistently lower in genetic prion disease patients. (2) C3, C4, and C9 protein levels were lower in the CSF from sCJD patients. This evidence concerns the gene C4A and prion disease.